EA202192760A1 - Трициклические соединения - Google Patents

Трициклические соединения

Info

Publication number
EA202192760A1
EA202192760A1 EA202192760A EA202192760A EA202192760A1 EA 202192760 A1 EA202192760 A1 EA 202192760A1 EA 202192760 A EA202192760 A EA 202192760A EA 202192760 A EA202192760 A EA 202192760A EA 202192760 A1 EA202192760 A1 EA 202192760A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutically acceptable
compound
tricyclic compounds
formula
methods
Prior art date
Application number
EA202192760A
Other languages
English (en)
Russian (ru)
Inventor
Сандрин Вендевилль
Original Assignee
Алигос Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алигос Терапьютикс, Инк. filed Critical Алигос Терапьютикс, Инк.
Publication of EA202192760A1 publication Critical patent/EA202192760A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA202192760A 2019-05-30 2020-05-27 Трициклические соединения EA202192760A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
PCT/US2020/034746 WO2020243199A1 (en) 2019-05-30 2020-05-27 Tricyclic compounds

Publications (1)

Publication Number Publication Date
EA202192760A1 true EA202192760A1 (ru) 2022-03-05

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192760A EA202192760A1 (ru) 2019-05-30 2020-05-27 Трициклические соединения

Country Status (19)

Country Link
US (1) US11136321B2 (cg-RX-API-DMAC7.html)
EP (1) EP3976618A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022534501A (cg-RX-API-DMAC7.html)
KR (1) KR20220016177A (cg-RX-API-DMAC7.html)
CN (1) CN113906029A (cg-RX-API-DMAC7.html)
AU (1) AU2020282707B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021023967A2 (cg-RX-API-DMAC7.html)
CA (1) CA3138938A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021003139A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021017202A2 (cg-RX-API-DMAC7.html)
EA (1) EA202192760A1 (cg-RX-API-DMAC7.html)
IL (1) IL287813A (cg-RX-API-DMAC7.html)
MA (1) MA56058A (cg-RX-API-DMAC7.html)
MX (1) MX2021014458A (cg-RX-API-DMAC7.html)
PE (1) PE20220427A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552953A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202113214QA (cg-RX-API-DMAC7.html)
TW (1) TW202110845A (cg-RX-API-DMAC7.html)
WO (1) WO2020243199A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220000874A1 (en) * 2019-05-30 2022-01-06 Aligos Therapeutics, Inc. Tricyclic compounds
US12703701B2 (en) * 2019-12-10 2026-08-11 Shanghai Hansoh Biomedical Co., Ltd. Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof
GB202103704D0 (en) * 2021-03-17 2021-04-28 Pathios Therapeutics Ltd Compounds
WO2022115384A1 (en) * 2020-11-24 2022-06-02 Aligos Therapeutics, Inc. Tricyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701273D0 (en) 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
WO2008157273A1 (en) 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
RU2016120763A (ru) * 2013-10-29 2017-12-05 Медивир Аб Ингибиторы респираторного синцитиального вируса
BR112018068177B1 (pt) 2016-03-09 2024-02-27 Emory University Composto, uso do composto e composição para eliminação do vírus da hepatite b com agentes antivirais
CN110066278B (zh) * 2017-06-01 2021-06-08 广东东阳光药业有限公司 稠合三环类化合物及其在药物中的应用

Also Published As

Publication number Publication date
BR112021023967A2 (pt) 2022-03-08
MA56058A (fr) 2022-04-06
TW202110845A (zh) 2021-03-16
CL2021003139A1 (es) 2022-09-23
EP3976618A1 (en) 2022-04-06
CN113906029A (zh) 2022-01-07
EP3976618A4 (en) 2023-01-04
JP2022534501A (ja) 2022-08-01
PH12021552953A1 (en) 2022-07-25
US20200407361A1 (en) 2020-12-31
CO2021017202A2 (es) 2022-01-17
MX2021014458A (es) 2022-01-06
WO2020243199A1 (en) 2020-12-03
PE20220427A1 (es) 2022-03-29
SG11202113214QA (en) 2021-12-30
CA3138938A1 (en) 2020-12-03
AU2020282707A1 (en) 2021-12-02
AU2020282707B2 (en) 2025-06-19
US11136321B2 (en) 2021-10-05
KR20220016177A (ko) 2022-02-08
IL287813A (en) 2022-01-01

Similar Documents

Publication Publication Date Title
CL2024000067A1 (es) Compuestos antivirales
PH12021552482A1 (en) Compounds targeting prmt5
SA522432955B1 (ar) Kras g12c مثبطات
PH12021500014A1 (en) Fused ring compounds
EA202193007A1 (ru) Соединения пирролидина
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
EA201991894A1 (ru) ПИПЕРИДИН-ЗАМЕЩЕННЫЕ ИНГИБИТОРЫ Mnk И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
EA201891703A1 (ru) Соединения бензопиразола и их аналоги
EA202092253A1 (ru) Замещенные производные имидазолидин-2-она в качестве ингибиторов prmt5
EA201992601A1 (ru) Конденсированное имидазопиперидиновое соединение, являющееся ингибитором jak
EA202090688A1 (ru) Бис-амидные соединения, активирующие саркомер, и варианты их применения
EA202193015A1 (ru) Ингибиторы cdk
PH12021550825A1 (en) Quinoline derivatives as alpha4beta7 integrin inhibitors
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
EA202190681A1 (ru) Амиды диметиламиноазетидина в качестве jak ингибиторов
PH12021552513A1 (en) Pyrrole compounds
EA202191991A1 (ru) Новые производные гетеротрициклического соединения и их применение
EA202190686A1 (ru) 5-7-членные гетероциклические амиды в качестве ингибиторов jak
MX2021007247A (es) Derivados de rapamicina.
PH12021552953A1 (en) Tricyclic compounds
MX2020013297A (es) Compuestos para el tratamiento o la prevencion de enfermedades hepaticas.
EA201692300A1 (ru) Производные карбоксамида
PH12021550452A1 (en) Methods of treating mycobacterial infections using tetracycline compounds
EA202191192A1 (ru) Кристаллические соли ингибитора плазменного калликреина
MX2021009717A (es) Sulfonamidas biciclicas.